Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year?
10:46am, Wednesday, 13'th Mar 2024
Here is how GSK (GSK) and Capricor Therapeutics (CAPR) have performed compared to their sector so far this year.
GSK: Has Blenrep's blockbuster status been restored?
03:31am, Friday, 08'th Mar 2024
GSK PLC (LSE:GSK, NYSE:GSK) cancer discovery Blenrep's blockbuster potential has been 'reawakened', according to Shore Capital. The broker was commenting after Thursday's phase III results, which sh
GSK's blood cancer drug meets main goal in late-stage trial; analysts tout comeback
06:41am, Thursday, 07'th Mar 2024
GSK said on Thursday a study showed its experimental drug Blenrep helped extend survival in patients with a type of blood cancer without symptoms worsening, marking a potential comeback for the drug a
GSK vs. VRTX: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 05'th Mar 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with GSK (GSK) and Vertex Pharmaceuticals (VRTX). But which of these two stocks presents investors with the better
WHO says resistance to GSK's HIV drug is growing
11:32am, Tuesday, 05'th Mar 2024
The World Health Organization said on Tuesday that data shows resistance to the drug is growing in patients receiving GSK's HIV drug, dolutegravir.
GSK's new HIV drug formula could support longer dosing intervals
01:50pm, Monday, 04'th Mar 2024
GSK said on Monday a new formulation of its HIV prevention and treatment drug could potentially be administered at least every four months, an improvement from the previous requirement of dosing every
Glaxo (GSK) Up 3.1% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 01'st Mar 2024
Glaxo (GSK) reported earnings 30 days ago. What's next for the stock?
GSK boss sees pay jump 51% in 2023
10:53am, Friday, 01'st Mar 2024
GSK PLC (LSE:GSK, NYSE:GSK) boss Emma Walmsley saw her overall pay rise 51% to around £13 million in 2023 after she received a large hike in performance-related bonuses. Some £11 million of the pay
GSK (GSK) Stock Declines While Market Improves: Some Information for Investors
07:01pm, Thursday, 29'th Feb 2024
In the most recent trading session, GSK (GSK) closed at $41.90, indicating a -1.04% shift from the previous trading day.
Investors Heavily Search GSK PLC Sponsored ADR (GSK): Here is What You Need to Know
10:01am, Thursday, 29'th Feb 2024
Zacks.com users have recently been watching Glaxo (GSK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
GSK settles another California lawsuit
03:31am, Thursday, 29'th Feb 2024
GSK PLC (LSE:GSK, NYSE:GSK) has confidentially settled a lawsuit in California that claimed its now-discontinued heartburn medication, Zantac, caused cancer. This agreement, ahead of a trial schedule
GSK settles another lawsuit on heartburn drug Zantac in California
02:24am, Thursday, 29'th Feb 2024
GSK agreed to confidentially settle another lawsuit in California that had alleged its discontinued heartburn drug Zantac caused cancer, the latest in a series of settlements made by the British drugm
Here's Why GSK (GSK) is a Strong Momentum Stock
10:56am, Wednesday, 28'th Feb 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why GSK (GSK) is a Strong Value Stock
10:46am, Tuesday, 27'th Feb 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
All You Need to Know About Glaxo (GSK) Rating Upgrade to Buy
01:00pm, Monday, 26'th Feb 2024
Glaxo (GSK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
